Cargando…

Formulation and evaluation of sublingual tablets containing Sumatriptan succinate

OBJECTIVE: Sumatriptan succinate is a selective 5-hydroxytryptamine-1 receptor agonist effective in the acute treatment of migraine headaches, having low bioavailability of about 15% orally due to first-pass metabolism. The purpose of this research was to mask the intensely bitter taste of Sumatript...

Descripción completa

Detalles Bibliográficos
Autores principales: Prajapati, Shailesh T, Patel, Parth B, Patel, Chhagan N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555012/
https://www.ncbi.nlm.nih.gov/pubmed/23373008
http://dx.doi.org/10.4103/2230-973X.104400